Mar. 23 -- FRIDAY, Jan. 18 (HealthDay News) -- A birth control skin patch used by many American women carries a risk of serious blood clots that is higher than the risk already recognized for the ...
The Company expects to submit the New Drug Application for Xulane Lo in the second half of 2025. A low dose combination hormonal patch was found to be effective for pregnancy prevention based on ...
December 9, 2011 — Voting in favor of the norelgestromin/ethinyl estradiol transdermal contraceptive patch (Ortho Evra, Jannsen), a US Food and Drug Administration (FDA) advisory panel today ...
Zafemy and Xulane are generic skin patches. They both contain the active ingredients norelgestromin and ethinyl estradiol. Zafemy and Xulane are prescribed to help prevent pregnancy. This article ...
Navigating the world of birth control can be overwhelming, especially given the sheer variety of options available today. From hormonal methods like the pill and patch to long-term solutions like IUDs ...
PRINCETON, NJ / ACCESSWIRE / July 18, 2023 / This month, Agile Therapeutics, Inc. (NASDAQ:AGRX) announced partnerships with FPA Women's Health and vitaCare Prescription Services that will expand ...
PITTSBURGH, May 8, 2025 /PRNewswire/ -- Viatris Inc. (VTRS) (Nasdaq: VTRS), a global healthcare company, today announced positive results of its Phase 3 study (NCT05139121) evaluating the ...
Birth control in the US right now is full of contradictions.
This is the fifth installment in a series of articles about the science of various aspects of college life. Any Brown student can schedule an appointment with Student Health Services to review various ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback